Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary

Print

| AAA

Week of June 1’s Top Stories Covered SpaceX IPO, First Autism ETF

BY | ETF Database

12:58 pm ET 06/09/26 | 0 VIEWS

Related Symbols
UFO
PCEF
ASD

Last week’s top articles on ETF Database and ETF Trends were closely connected to current events such as SpaceX’s expected IPO and tech stock performance.The most-read article last week was SpaceX IPO to Boost Aerospace ETFs? Try UFO. In it, Nick Peters-Golden covered the pending SpaceX IPO and how it could affect the aerospace industry as represented in ETFs like the Procure Space ETF (UFO ). Peters-Golden’s article was followed by 3 Reasons to Invest in Closed End Funds This Summer, by Nick Wodeshick. The piece highlighted the benefits of investing in closed-end funds and featured the Invesco CEF Income Composite ETF (PCEF C+), which offers wide ranging exposure to the category. Todd Shriber wrote the third-most read article from last week. Palantir Rally Renews This ETF’s Shine discussed a strong week of performance by Palantir’s stock, which in turn boosted the share price of the Direxion Daily PLTR Bull 2X Shares (PLTU ). Investing With Purpose: Defiance Launches Autism Impact ETF fell into the No. 4 spot in the rankings. In it, Ben Hernandez covered the rollout of the first ETF, the Defiance Autism Impact ETF (ASD), to focus exclusively on companies that support the neurodivergent population, especially those with autism spectrum disorder. Finally, Zandile Chiwanza and Elle Caruso Fitzgerald debated whether investors should be adding space ETFs to their portfolios or looking for similar thematic exposures elsewhere. Bull vs Bear: Are Space ETFs Ready for Liftoff or Grounded by Macro Headwinds? was the fifth-most-read article during the week that began June 1, 2026. For more news, information, and analysis, visit the Thematic Investing Content Hub. VettaFi LLC (“VettaFi”) is the index provider for UFO and ASD, for which it receives an index licensing fee. However, UFO and ASD are not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of UFO or ASD.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.